239 related articles for article (PubMed ID: 8987976)
1. Kinetically controlled folding of the serpin plasminogen activator inhibitor 1.
Wang Z; Mottonen J; Goldsmith EJ
Biochemistry; 1996 Dec; 35(51):16443-8. PubMed ID: 8987976
[TBL] [Abstract][Full Text] [Related]
2. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.
Jankun J; Specht Z; Szkudlarek M; Greenfield R; Gaikwad B; Trifonov L; Vaugeois J; Aleem AM; Basrur V; Selman SH; Zavodszky MI; Skrzypczak-Jankun E
Int J Mol Med; 2006 Mar; 17(3):437-47. PubMed ID: 16465390
[TBL] [Abstract][Full Text] [Related]
4. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
[TBL] [Abstract][Full Text] [Related]
5. Specific interactions of serpins in their native forms attenuate their conformational transitions.
Na YR; Im H
Protein Sci; 2007 Aug; 16(8):1659-66. PubMed ID: 17600149
[TBL] [Abstract][Full Text] [Related]
6. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
[TBL] [Abstract][Full Text] [Related]
7. The reduced, denatured somatomedin B domain of vitronectin refolds into a stable, biologically active molecule.
Kamikubo Y; Kroon G; Curriden SA; Dyson HJ; Loskutoff DJ
Biochemistry; 2006 Mar; 45(10):3297-306. PubMed ID: 16519524
[TBL] [Abstract][Full Text] [Related]
8. Global analysis of the acid-induced and urea-induced unfolding of staphylococcal nuclease and two of its variants.
Ionescu RM; Eftink MR
Biochemistry; 1997 Feb; 36(5):1129-40. PubMed ID: 9033404
[TBL] [Abstract][Full Text] [Related]
9. Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.
Björquist P; Ehnebom J; Inghardt T; Hansson L; Lindberg M; Linschoten M; Strömqvist M; Deinum J
Biochemistry; 1998 Feb; 37(5):1227-34. PubMed ID: 9477948
[TBL] [Abstract][Full Text] [Related]
10. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.
Gils A; Knockaert I; Declerck PJ
Biochemistry; 1996 Jun; 35(23):7474-81. PubMed ID: 8652525
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.
Nar H; Bauer M; Stassen JM; Lang D; Gils A; Declerck PJ
J Mol Biol; 2000 Mar; 297(3):683-95. PubMed ID: 10731421
[TBL] [Abstract][Full Text] [Related]
12. Construction and characterization of monomeric tryptophan repressor: a model for an early intermediate in the folding of a dimeric protein.
Shao X; Hensley P; Matthews CR
Biochemistry; 1997 Aug; 36(32):9941-9. PubMed ID: 9245428
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of folding of the IgG binding domain of peptostreptococcal protein L.
Scalley ML; Yi Q; Gu H; McCormack A; Yates JR; Baker D
Biochemistry; 1997 Mar; 36(11):3373-82. PubMed ID: 9116017
[TBL] [Abstract][Full Text] [Related]
14. A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state.
Mathiasen L; Dupont DM; Christensen A; Blouse GE; Jensen JK; Gils A; Declerck PJ; Wind T; Andreasen PA
Mol Pharmacol; 2008 Sep; 74(3):641-53. PubMed ID: 18559377
[TBL] [Abstract][Full Text] [Related]
15. The slow folding reaction of barstar: the core tryptophan region attains tight packing before substantial secondary and tertiary structure formation and final compaction of the polypeptide chain.
Sridevi K; Juneja J; Bhuyan AK; Krishnamoorthy G; Udgaonkar JB
J Mol Biol; 2000 Sep; 302(2):479-95. PubMed ID: 10970747
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of latency in plasminogen activator inhibitor-1.
Mottonen J; Strand A; Symersky J; Sweet RM; Danley DE; Geoghegan KF; Gerard RD; Goldsmith EJ
Nature; 1992 Jan; 355(6357):270-3. PubMed ID: 1731226
[TBL] [Abstract][Full Text] [Related]
17. Identification of residual structure within denatured antichymotrypsin: implications for serpin folding and misfolding.
Pearce MC; Cabrita LD; Rubin H; Gore MG; Bottomley SP
Biochem Biophys Res Commun; 2004 Nov; 324(2):729-35. PubMed ID: 15474488
[TBL] [Abstract][Full Text] [Related]
18. Conformational states in denaturants of cytochrome c and horseradish peroxidases examined by fluorescence and circular dichroism.
Tsaprailis G; Chan DW; English AM
Biochemistry; 1998 Feb; 37(7):2004-16. PubMed ID: 9485327
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the folding and unfolding reactions of single-chain monellin: evidence for multiple intermediates and competing pathways.
Patra AK; Udgaonkar JB
Biochemistry; 2007 Oct; 46(42):11727-43. PubMed ID: 17902706
[TBL] [Abstract][Full Text] [Related]
20. Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate, and cleaved forms.
Sancho E; Declerck PJ; Price NC; Kelly SM; Booth NA
Biochemistry; 1995 Jan; 34(3):1064-9. PubMed ID: 7827021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
